Erfan Asgari

Erfan Asgari

Auto-generated profile, based on publicly available information

Erfan Asgari

Department of Experimental Medicine University of Genova Italy

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 October 2025 in The FEBS Journal
Verified
Journal Article
Open access
Maria Rosaria CoppolaMaria Rosaria Coppola
Maria Rosaria Coppola
DBDeianira Bellitto
Deianira Bellitto
EAErfan Asgari
Erfan Asgari
VBVirginia Bazzurro
Virginia Bazzurro
GCGiorgia Casucci
Giorgia Casucci
MTMichela Tonetti
Michela Tonetti
Catel–Manzke syndrome (CMS) is a rare genetic disorder associated with mutations in the TDP‐glucose 4,6‐dehydratase ( TGDS ) gene, the function of which in vertebrates remains unclear. This study investigated the zebrafish ortholog tgds to assess its suitability for modeling the disease. During development, the tgds transcript exhibits a conserved biphasic expression pattern with an initial maternal contribution followed by a second wave of expression after gastrulation. Recombinant zebrafish Tgds expressed in Escherichia coli demonstrated UDP‐D‐glucose 4,6‐dehydratase ( EC4.2.1.76 ) activity, similar to TGDS orthologs in lower eukaryotes, where it acts as the first step in the L‐rhamnose biosynthetic pathway. This finding suggests the presence of a yet unidentified pathway in vertebrates. Furthermore, CMS‐associated mutations in conserved residues significantly impair enzyme activity and stability. CRISPR/Cas9‐mediated F 0 knockout of tgds resulted in a range of developmental defects in zebrafish. In particular, craniofacial cartilage alterations, associated with a decrease in sulfate glycosaminoglycan content, mirrored some skeletal features observed in humans with CMS. These findings establish the zebrafish as a relevant model to further explore CMS pathogenesis and the in vivo function of tgds .